Breaking News Instant updates and real-time market news.

ACET

Aceto

$0.42 /

-0.625 (-59.81%)

12:41
02/20/19
02/20
12:41
02/20/19
12:41

Aceto receives Nasdaq notice due to delay in filing Form 10-Q

Aceto Corporation announced that it received a notification from the Nasdaq Stock Market on February 13, 2019 informing Aceto that since Aceto had not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2018, Aceto was not in compliance with Nasdaq Listing Rule 5250c1. The Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission. The Nasdaq notification letter specifies that Aceto has 60 calendar days, or until April 14, 2019, to submit a plan to regain compliance with the Listing Rule. If Nasdaq accepts the plan from Aceto, Nasdaq can grant an exception of up to 180 calendar days from the Quarterly Report's due date, or until August 12, 2019, to regain compliance. Aceto filed the Quarterly Report prior to the opening of trading on February 20, 2019. The Quarterly Report, among other things, describes that on February 19, 2019, the Company and certain of its U.S. subsidiaries each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code.

ACET Aceto
$0.42 /

-0.625 (-59.81%)

04/19/18
Craig-Hallum downgrades Aceto to Sell after guidance withdrawn, dividend cut
04/19/18 Craig-Hallum
Aceto downgraded to Sell from Hold at Craig-Hallum
04/19/18 Wells Fargo
Wells says bottom has not been reached in generics pricing
04/19/18 Canaccord
Aceto double downgraded to Sell at Canaccord

TODAY'S FREE FLY STORIES

Recommendations
Rheinmetall named Catalyst Call Buy idea at Deutsche Bank » 07:57
08/10/20
08/10
07:57
08/10/20
07:57
RNMBY

Rheinmetall

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNMBY Rheinmetall
$0.00 /

+ (+0.00%)

08/07/20 Deutsche Bank
Rheinmetall price target raised to EUR 100 from EUR 80 at Deutsche Bank
08/07/20 Oddo BHF
Rheinmetall upgraded to Buy from Neutral at Oddo BHF
05/13/20 Morgan Stanley
Rheinmetall price target raised to EUR 85 from EUR 82 at Morgan Stanley
05/11/20 Oddo BHF
Rheinmetall downgraded to Neutral from Buy at Oddo BHF
Hot Stocks
Aquestive Therapeutics receives Fast Track designation for AQST-108 » 07:57
08/10/20
08/10
07:57
08/10/20
07:57
AQST

Aquestive Therapeutics

$6.29 /

+0.23 (+3.80%)

Aquestive Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

05/22/20 H.C. Wainwright
Aquestive Therapeutics price target raised to $15 from $13 at H.C. Wainwright
03/16/20 Wedbush
Aquestive Therapeutics price target lowered to $31 from $36 at Wedbush
02/10/20 Wedbush
Wedbush delays launch estimates for Libervant, ups Aquestive Therapeutics target
02/10/20 Wedbush
Aquestive price target raised to $36 at Wedbush after FDA accepts NDA
AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

  • 13
    Dec
AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

Recommendations
Carvana price target raised to $250 from $127 at Oppenheimer » 07:56
08/10/20
08/10
07:56
08/10/20
07:56
CVNA

Carvana

$191.81 /

-31.26 (-14.01%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$191.81 /

-31.26 (-14.01%)

CVNA Carvana
$191.81 /

-31.26 (-14.01%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 BofA
Carvana downgraded to Neutral from Buy at BofA
08/07/20 BofA
Carvana downgraded to Neutral from Buy at BofA
08/06/20 Wells Fargo
Carvana price target raised to $200 from $175 at Wells Fargo
CVNA Carvana
$191.81 /

-31.26 (-14.01%)

  • 19
    May
CVNA Carvana
$191.81 /

-31.26 (-14.01%)

CVNA Carvana
$191.81 /

-31.26 (-14.01%)

CVNA Carvana
$191.81 /

-31.26 (-14.01%)

Hot Stocks
Ocugen receives Orphan Drug designation for OCU400 gene therapy » 07:56
08/10/20
08/10
07:56
08/10/20
07:56
OCGN

Ocugen

$0.55 /

+0.0904 (+19.77%)

Ocugen announced the U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

06/01/20 H.C. Wainwright
H.C. Wainwright downgrades Ocugen to Neutral after OCU300 discontinuation
06/01/20 H.C. Wainwright
Ocugen downgraded to Neutral from Buy at H.C. Wainwright
03/30/20 H.C. Wainwright
H.C. Wainwright encouraged Ocugen's Phase 3 trial of OCU300 still on track
12/20/19 H.C. Wainwright
Ocugen initiated with a Buy at H.C. Wainwright
OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

Recommendations
Wix.com price target raised to $342 from $220 at Deutsche Bank » 07:55
08/10/20
08/10
07:55
08/10/20
07:55
WIX

Wix.com

$291.82 /

-15.89 (-5.16%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

08/07/20 Oppenheimer
Wix.com price target raised to $350 from $305 at Oppenheimer
08/07/20 JMP Securities
Wix.com price target raised to $363 from $210 at JMP Securities
07/23/20 Citi
Wix.com price target raised to $330 from $220 at Citi
07/22/20 KeyBanc
Wix.com price target raised to $325 from $275 at KeyBanc
WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

Conference/Events
Goldman Sachs consumer goods analyst to hold an analyst/industry webcast » 07:55
08/10/20
08/10
07:55
08/10/20
07:55

Consumer Goods Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Amazon.com price target raised to $3,775 from $2,900 at Loop Capital » 07:54
08/10/20
08/10
07:54
08/10/20
07:54
AMZN

Amazon.com

$3,167.40 /

-54.81 (-1.70%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
07/31/20 BMO Capital
Amazon.com price target raised to $3,700 from $3,500 at BMO Capital
07/31/20 RBC Capital
Amazon.com price target raised to $3,800 from $3,300 at RBC Capital
AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

Earnings
Front Yard Residential reports Q2 AFFO 9c, consensus 10c » 07:53
08/10/20
08/10
07:53
08/10/20
07:53
RESI

Front Yard Residential

$9.14 /

+0.245 (+2.76%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RESI Front Yard Residential
$9.14 /

+0.245 (+2.76%)

RESI Front Yard Residential
$9.14 /

+0.245 (+2.76%)

06/12/20 Northland
Front Yard Residential upgraded to Outperform from Market Perform at Northland
06/08/20 JMP Securities
Front Yard upgraded to Outperform from Market Perform at JMP Securities
05/18/20 Credit Suisse
Front Yard Residential reinstated with an Outperform at Credit Suisse
02/19/20 Northland
Front Yard Residential downgraded to Market Perform from Outperform at Northland
RESI Front Yard Residential
$9.14 /

+0.245 (+2.76%)

Recommendations
Apple price target raised to $480 from $440 at Deutsche Bank » 07:53
08/10/20
08/10
07:53
08/10/20
07:53
AAPL

Apple

$444.41 /

-10.98 (-2.41%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

07:26 Today Wedbush
Apple price target raised to $515 from $475 at Wedbush
07:02 Today KeyBanc
Survey indicates strengthening recovery in Apple iPhone sales, says KeyBanc
08/06/20 KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
08/06/20 Barclays
SiTime price target raised to $75 from $50 at Barclays
AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

Recommendations
Waste Connections price target raised to $118 from $106 at Jefferies » 07:52
08/10/20
08/10
07:52
08/10/20
07:52
WCN

Waste Connections

$101.85 /

-1.36 (-1.32%)

Jefferies analyst Hamzah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

06:42 Today Stifel
Waste Connections price target raised to $115 from $110 at Stifel
08/07/20 UBS
Waste Connections price target raised to $116 from $108 at UBS
07/20/20 KeyBanc
Waste Connections price target raised to $115 from $105 at KeyBanc
07/10/20 BMO Capital
Waste Connections price target raised to $106 from $104 at BMO Capital
WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

Hot Stocks
Wave Life Sciences expects cash, cash equivalents to fund operations into 4Q21 » 07:51
08/10/20
08/10
07:51
08/10/20
07:51
WVE

Wave Life Sciences

$9.13 /

+0.13 (+1.44%)

Wave expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
01/02/20 H.C. Wainwright
H.C. Wainwright cuts Wave Life price target to $20, but 'not throwing in towel'
12/31/19
Fly Intel: Top five analyst actions
12/31/19 Guggenheim
Wave Huntington's data 'mediocre, but not a zero,' says Guggenheim
WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

Recommendations
Lyft price target lowered to $40 from $50 at Jefferies » 07:51
08/10/20
08/10
07:51
08/10/20
07:51
LYFT

Lyft

$30.19 /

-2.145 (-6.63%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

07:41 Today Credit Suisse
Lyft price target lowered to $66 from $75 at Credit Suisse
08/05/20 Deutsche Bank
Lyft price target lowered to $57 from $60 at Deutsche Bank
07/22/20 Raymond James
Lyft resumed with a Market Perform at Raymond James
07/14/20
Fly Intel: Top five analyst downgrades
LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

Recommendations
T-Mobile price target raised to $150 from $140 at Deutsche Bank » 07:51
08/10/20
08/10
07:51
08/10/20
07:51
TMUS

T-Mobile

$115.08 /

+7.04 (+6.52%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMUS T-Mobile
$115.08 /

+7.04 (+6.52%)

TMUS T-Mobile
$115.08 /

+7.04 (+6.52%)

08/07/20 JPMorgan
T-Mobile price target raised to $140 from $110 at JPMorgan
08/07/20 Goldman Sachs
T-Mobile price target raised to $135 from $123 at Goldman Sachs
07/29/20
Fly Intel: Top five analyst initiations
07/29/20
Fly Intel: Top five analyst downgrades
TMUS T-Mobile
$115.08 /

+7.04 (+6.52%)

  • 24
    Jun
TMUS T-Mobile
$115.08 /

+7.04 (+6.52%)

TMUS T-Mobile
$115.08 /

+7.04 (+6.52%)

TMUS T-Mobile
$115.08 /

+7.04 (+6.52%)

Earnings
Wave Life Sciences reports Q2 EPS ($1.15), consensus (97c) » 07:51
08/10/20
08/10
07:51
08/10/20
07:51
WVE

Wave Life Sciences

$9.13 /

+0.13 (+1.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
01/02/20 H.C. Wainwright
H.C. Wainwright cuts Wave Life price target to $20, but 'not throwing in towel'
12/31/19
Fly Intel: Top five analyst actions
12/31/19 Guggenheim
Wave Huntington's data 'mediocre, but not a zero,' says Guggenheim
WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

WVE Wave Life Sciences
$9.13 /

+0.13 (+1.44%)

Upgrade
FedEx upgraded to Outperform from at Bernstein » 07:50
08/10/20
08/10
07:50
08/10/20
07:50
FDX

FedEx

$183.45 /

+11.28 (+6.55%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$183.45 /

+11.28 (+6.55%)

FDX FedEx
$183.45 /

+11.28 (+6.55%)

06:22 Today Bernstein
FedEx upgraded to Outperform from Market Perform at Bernstein
08/07/20 Stephens
FedEx named a Best Idea at Stephens
07/06/20 Argus
FedEx upgraded to Buy from Hold earlier at Argus
07/02/20 Deutsche Bank
FedEx price target raised to $150 from $128 at Deutsche Bank
FDX FedEx
$183.45 /

+11.28 (+6.55%)

FDX FedEx
$183.45 /

+11.28 (+6.55%)

FDX FedEx
$183.45 /

+11.28 (+6.55%)

FDX FedEx
$183.45 /

+11.28 (+6.55%)

Hot Stocks
Intra-Cellular plans to initiate clinical program of lumateperone in MDD in 2020 » 07:49
08/10/20
08/10
07:49
08/10/20
07:49
ITCI

Intra-Cellular

$20.91 /

+0.32 (+1.55%)

We plan to initiate our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

06/04/20 Cantor Fitzgerald
Cantor reiterates $37 target on Intra-Cellular ahead of Phase 3 data
03/03/20 BTIG
Intra-Cellular price target lowered to $68 from $73 at BTIG
02/20/20
Fly Intel: Top five analyst initiations
02/19/20 Evercore ISI
Intra-Cellular initiated with an Outperform at Evercore ISI
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

  • 08
    Jan
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

Hot Stocks
Intra-Cellular sees topline results from Study 403 in 2H21 » 07:49
08/10/20
08/10
07:49
08/10/20
07:49
ITCI

Intra-Cellular

$20.91 /

+0.32 (+1.55%)

Lumateperone in Bipolar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

06/04/20 Cantor Fitzgerald
Cantor reiterates $37 target on Intra-Cellular ahead of Phase 3 data
03/03/20 BTIG
Intra-Cellular price target lowered to $68 from $73 at BTIG
02/20/20
Fly Intel: Top five analyst initiations
02/19/20 Evercore ISI
Intra-Cellular initiated with an Outperform at Evercore ISI
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

  • 08
    Jan
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

Hot Stocks
Biohaven Pharmaceutical reports $263.9M cash position as of June 30 » 07:48
08/10/20
08/10
07:48
08/10/20
07:48
BHVN

Biohaven Pharmaceutical

$67.67 /

+4.24 (+6.68%)

Cash and restricted cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 Piper Sandler
Biohaven migraine competitor shows constipation signal, says Piper Sandler
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

Earnings
Intra-Cellular reports Q2 EPS (96c), consensus (91c) » 07:47
08/10/20
08/10
07:47
08/10/20
07:47
ITCI

Intra-Cellular

$20.91 /

+0.32 (+1.55%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

06/04/20 Cantor Fitzgerald
Cantor reiterates $37 target on Intra-Cellular ahead of Phase 3 data
03/03/20 BTIG
Intra-Cellular price target lowered to $68 from $73 at BTIG
02/20/20
Fly Intel: Top five analyst initiations
02/19/20 Evercore ISI
Intra-Cellular initiated with an Outperform at Evercore ISI
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

  • 08
    Jan
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

Earnings
Biohaven Pharmaceutical reports Q2 non-GAAP EPS ($2.55), consensus ($2.61) » 07:47
08/10/20
08/10
07:47
08/10/20
07:47
BHVN

Biohaven Pharmaceutical

$67.67 /

+4.24 (+6.68%)

Reports Q2 revenue $9.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 Piper Sandler
Biohaven migraine competitor shows constipation signal, says Piper Sandler
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

Recommendations
Restaurant Brands price target raised to $75 from $57 at Deutsche Bank » 07:47
08/10/20
08/10
07:47
08/10/20
07:47
QSR

Restaurant Brands

$53.68 /

-1.515 (-2.74%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

08/07/20 Evercore ISI
Restaurant Brands downgraded to In Line from Outperform at Evercore ISI
08/04/20 RBC Capital
Restaurant Brands price target raised to $63 from $57 at RBC Capital
06/30/20 SunTrust
Restaurant Brands price target raised to $63 from $60 at SunTrust
05/18/20 Standpoint Research
Restaurant Brands initiated with a Buy at Standpoint Research
QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

  • 04
    Sep
QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

Hot Stocks
Paratek Pharmaceuticals expects cash to fund operations through end of 2023 » 07:46
08/10/20
08/10
07:46
08/10/20
07:46
PRTK

Paratek Pharmaceuticals

$4.57 /

+0.075 (+1.67%)

The Company now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/01/20 H.C. Wainwright
Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

Earnings
Paratek Pharmaceuticals sees 2020 revenue $78M-$83M, consensus $81.16M  07:45
08/10/20
08/10
07:45
08/10/20
07:45
PRTK

Paratek Pharmaceuticals

$4.57 /

+0.075 (+1.67%)

 
ShowHide Related Items >><<
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/01/20 H.C. Wainwright
Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

Earnings
Paratek Pharmaceuticals reports Q2 EPS (53c), consensus (6c) » 07:45
08/10/20
08/10
07:45
08/10/20
07:45
PRTK

Paratek Pharmaceuticals

$4.57 /

+0.075 (+1.67%)

Reports Q revenue $9.3M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/01/20 H.C. Wainwright
Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

Recommendations
Norfolk Southern named Catalyst Call Buy idea at Deutsche Bank » 07:44
08/10/20
08/10
07:44
08/10/20
07:44
NSC

Norfolk Southern

$198.79 /

+2.87 (+1.46%)

, UPS

UPS

$156.84 /

+11.51 (+7.92%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
$198.79 /

+2.87 (+1.46%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

NSC Norfolk Southern
$198.79 /

+2.87 (+1.46%)

07/30/20 Wells Fargo
Norfolk Southern price target raised to $213 from $201 at Wells Fargo
07/30/20 Credit Suisse
Norfolk Southern price target raised to $216 from $199 at Credit Suisse
07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 TD Securities
Norfolk Southern upgraded to Buy from Hold at TD Securities
UPS UPS
$156.84 /

+11.51 (+7.92%)

07:11 Today UBS
UPS price target raised to $162 from $150 at UBS
08/06/20 Oppenheimer
UPS price target raised to $153 from $106 at Oppenheimer
08/03/20 Standpoint Research
UPS downgraded to Hold from Buy at Standpoint Research
08/03/20 Stephens
UPS price target raised to $150 from $105 at Stephens
NSC Norfolk Southern
$198.79 /

+2.87 (+1.46%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.